The content is available as a PDF (350.3 KB).
letter . 2020 May 16:hpaa076. doi: 10.1093/ajh/hpaa076
COVID-19 and ACEI/ARB: NOT ASSOCIATED?
Adrija Hajra
1,✉, Dhrubajyoti Bandyopadhyay
2
Adrija Hajra, MBBS, MD, MRCP
1
Jacobi Medical Center/ Albert Einstein College of Medicine, Bronx, New York
Find articles by Adrija Hajra
Dhrubajyoti Bandyopadhyay, MBBS, MD
2
Icahn School of Medicine at Mount Sinai/Mount Sinai St Luke’s Roosevelt Hospital, Manhattan, New York
Find articles by Dhrubajyoti Bandyopadhyay
1
Jacobi Medical Center/ Albert Einstein College of Medicine, Bronx, New York
2
Icahn School of Medicine at Mount Sinai/Mount Sinai St Luke’s Roosevelt Hospital, Manhattan, New York
✉
Corresponding author: Adrija Hajra, MBBS, MD, MRCP (UK), Jacobi Medical Center/ Albert Einstein College of Medicine, Bronx, New York , Email: adrija847@gmail.com
Received 2020 May 5.
Keywords: COVID-19, hypertension, ACEI/ARB
© American Journal of Hypertension, Ltd 2020. All rights reserved. For Permissions, please email: journals.permissions@oup.com
This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model)
This article is made available via the PMC Open Access Subset for unrestricted re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the COVID-19 pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections.
PMCID: PMC7239222 PMID: 32415832
See "Response to COVID-19 and ACEI/ARB: NOT ASSOCIATED?", hpaa077.
See commentary "Response to COVID-19 and ACEI/ARB: NOT ASSOCIATED?", hpaa077.